Surgicel® granuloma mimicking ovarian cancer: A case report

  • Authors:
    • Luigi Cormio
    • Gennaro Cormio
    • Giuseppe Di Fino
    • Carmen Scavone
    • Francesca Sanguedolce
    • Vera Loizzi
    • Giuseppe Carrieri
  • View Affiliations

  • Published online on: June 8, 2016     https://doi.org/10.3892/ol.2016.4689
  • Pages: 1083-1084
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Surgicel® is an absorbable sterile mesh composed of oxidized cellulose that is used to control intraoperative capillary or venous bleeding, due to its capacity to bind hemoglobin, thus allowing the formation of an artificial clot. In the present study, a large granuloma mimicking ovarian cancer, which developed following placement of a Surgicel® sponge during a combined pubovaginal sling procedure and cystocele repair, is reported. The aim of the present case report is to emphasize the fact that hemostatic measures should be removed following their use, and to alert surgeons to the risk of using and leaving in situ oxidized cellulose. Furthermore, accurate evaluation of the surgical history of the patient should always be performed prior to attempting surgery.

Introduction

Surgicel® (Johnson & Johnson Medical Ltd., Wokingham, UK) is an absorbable sterile mesh composed of oxidized cellulose, which is used to control intraoperative capillary or venous bleeding (1). Surgicel® binds hemoglobin, allowing the formation of an artificial clot (2). Although the manufacturer recommends its removal following achievement of hemostasis, Surgicel® is frequently left in situ to reabsorb spontaneously, typically with no untoward effects (3).

Adverse reactions to Surgicel® include burning, stinging sensation or, more rarely, a foreign body reaction (4,5). It has been reported that 40% of foreign body reactions are diagnosed within the initial year subsequent to surgery, and 50% are discovered ≥5 years following surgery (68). The majority of these complications occur outside the abdominal cavity, and a limited number of cases of Surgicel®-associated granuloma linked to gynecological surgery have been reported thus far (68).

The present study reports a case of Surgicel®-associated granuloma mimicking ovarian cancer following a combined pubovaginal sling procedure and cystocele repair, and reviews the literature concerning this rare pathological condition. Written informed consent was obtained from the patient.

Case report

In June 2012, a 67-year-old Caucasian woman underwent a combined pubovaginal sling procedure and cystocele repair at the Department of Urology and Renal Transplantation, University of Foggia (Foggia, Italy), using a large graft of autologous rectus muscle fascia, for the treatment of anterior genital prolapse with urinary stress incontinence. A Surgicel® bolster purchased from Johnson & Johnson Medical Ltd., was placed in each perivesical space to achieve hemostasis. The postoperative course was uneventful. At six-month follow-up, the patient complained of irritative voiding symptoms, which had progressively increased over the previous month. Urine culture was negative. Pelvic and transvaginal ultrasound revealed an 89-mm cystic lesion, with a 37-mm hyperechoic area on its wall, located in the right perivesical space (Fig. 1). Magnetic resonance imaging (MRI) confirmed the presence of a cystic lesion with a thick solid inner area (Fig. 2). The cystic walls presented intense contrast enhancement, whereas the solid area did not exhibit any increase in signal following administration of gadolinium (MultiHance®, Bracco Diagnostics Inc., Monroe Township, NJ, USA). There was no sign of bladder or rectal invasion and no apparent lymph node involvement. The level of CA125 serum tumor marker was 10 U/ml, which was within the normal range (<35 U/ml). Transperitoneal laparoscopic exploration revealed a large extraperitoneal mass arising from the right perivesical space and compressing the right ovary, which was normal in appearance. The mass was excised, and was observed to contain dark-brown particulate matter. Pathological examination revealed the presence of a large plasma cellular and granulocytic reaction, suggesting the occurrence of a foreign body reaction around the cellulose fibers (data not shown). Diagnosis of a Surgicel®-associated abscess was established, and one month subsequent to surgery the irritative voiding symptoms experienced by the patient had completely ceased.

Discussion

Intraoperative use of adjuvant hemostatics has become a common practice in gynecological and other types of surgery (2). Surgicel® is frequently used for hemostasis in a number of surgical procedures (2). Absorption of Surgicel® commences within 24 h following surgery, and complete resorption typically occurs within 4–8 weeks (9). It is common for oxidized cellulose to appear as a mass during the immediate postoperative period, and this should not be confused with a postoperative abscess (9), tumor (10) or hematoma (11). Radiological features are nonspecific, and differential diagnosis may be particularly difficult, as the lesion may exhibit a tumor-like appearance (12).

The computed tomography (CT) features of Surgicel®-associated granuloma include focal or linear collections of mixed attenuation located in or near the operative site, as well as pockets of air and absence of contrast enhancement and air-fluid levels (9). Over time, these pockets of air are completely replaced by soft tissue, leading to the formation of a foreign body granuloma (9). This granuloma may clinically and radiologically resemble a neoplastic lesion, and may therefore be a diagnostic challenge (6).

MRI findings are nonspecific, although the presence of hypointense stripes inside a cystic-like cavity on T2 weighted images is considered to be a characteristic sign of Surgicel®-associated granuloma (13). Despite the high accuracy of positron emission tomography (PET)/CT scanning, this method may produce false-positive results in cases of foreign body granuloma, possibly as a consequence of localized inflammation mimicking malignant tissue glucose uptake (14). Imperiale et al (8) reported the case of a patient with ovarian cancer where combined 18F-fluorodeoxyglucose PET/CT suggested isolated cancer relapse. However, the lesion was surgically removed and demonstrated to be a foreign body granuloma (8).

The present case has been reported in order to alert surgeons to the risk of using and leaving in situ oxidized cellulose. Furthermore, accurate evaluation of the surgical history of the patient should always be performed prior to attempting surgery.

References

1 

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML and Lawson JH: A comprehensive review of topical hemostatic agents: Efficacy and recommendations for use. Ann Surg. 251:217–228. 2010. View Article : Google Scholar : PubMed/NCBI

2 

Hadi HI, Maw A and Hay DJ: A simple technique to control iatrogenic solid organ injury haemorrhage. Surgeon. 2:339–361. 2004. View Article : Google Scholar : PubMed/NCBI

3 

Sabel M and Stummer W: The use of local agents: Surgicel and Surgifoam. Eur Spine J. 13(Suppl 1): S97–S101. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Rappaport W and Haynes K: The retained surgical sponge following intra-abdominal surgery. A continuing problem. Arch Surg. 125:405–407. 1990. View Article : Google Scholar : PubMed/NCBI

5 

Buckley SC and Broome JC: A foreign body reaction to Surgicel(R) mimicking an abscess or tumour recurrence. Br J Neurosurg. 9:561–563. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Deger RB, LiVolsi VA and Noumoff JS: Foreign body reaction (gossypiboma) masking as recurrent ovarian cancer. Gynecol Oncol. 56:94–96. 1995. View Article : Google Scholar : PubMed/NCBI

7 

Gao HW, Lin CK, Yu CP, Yu MS and Chen A: Oxidized cellulose (Surgicel) granuloma mimicking a primary ovarian tumor. Int J Gynecol Pathol. 21:422–423. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Imperiale L, Marchetti C, Salerno L, Iadarola R, Bracchi C, Vertechy L, di Francesco L, Musella A, Bevilacqua E, Pennesi P, et al: Nonabsorbable suture granuloma mimicking ovarian cancer recurrence at combined positron emission tomography/computed tomography evaluation: A case report. J Med Case Rep. 8:2022014. View Article : Google Scholar : PubMed/NCBI

9 

Young ST, Paulson EK, McCann RL and Baker ME: Appearance of oxidized cellulose (Surgicel) on postoperative CT scans: Similarity to postoperative abscess. AJR Am J Roentgenol. 160:275–277. 1993. View Article : Google Scholar : PubMed/NCBI

10 

Sandhu GS, Elexpuru-Camiruaga JA and Buckley S: Oxidized cellulose (Surgicel) granulomata mimicking tumour recurrence. Br J Neurosurg. 10:617–619. 1996. View Article : Google Scholar : PubMed/NCBI

11 

van Gelderen F and Swinnen J: Appearance of oxidized cellulose (Surgicel) on abdominal radiographs. AJR Am J Roentgenol. 167:15931996. View Article : Google Scholar : PubMed/NCBI

12 

Kim SR, Baik HK and Park YW: Retained surgical sponge presenting as a pelvic tumor after 25 years. Int J Gynaecol Obstet. 82:223–225. 2003. View Article : Google Scholar : PubMed/NCBI

13 

Oto A, Remer EM, O'Malley CM, Tkach JA and Gill IS: MR characteristics of oxidized cellulose (Surgicel). AJR Am J Roentgenol. 172:1481–1484. 1999. View Article : Google Scholar : PubMed/NCBI

14 

Ghersin E, Keidar Z, Brook OR, Amendola MA and Engel A: A new pitfall on abdominal PET/CT: A retained surgical sponge. J Comput Assist Tomogr. 28:839–841. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August-2016
Volume 12 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cormio L, Cormio G, Di Fino G, Scavone C, Sanguedolce F, Loizzi V and Carrieri G: Surgicel® granuloma mimicking ovarian cancer: A case report. Oncol Lett 12: 1083-1084, 2016.
APA
Cormio, L., Cormio, G., Di Fino, G., Scavone, C., Sanguedolce, F., Loizzi, V., & Carrieri, G. (2016). Surgicel® granuloma mimicking ovarian cancer: A case report. Oncology Letters, 12, 1083-1084. https://doi.org/10.3892/ol.2016.4689
MLA
Cormio, L., Cormio, G., Di Fino, G., Scavone, C., Sanguedolce, F., Loizzi, V., Carrieri, G."Surgicel® granuloma mimicking ovarian cancer: A case report". Oncology Letters 12.2 (2016): 1083-1084.
Chicago
Cormio, L., Cormio, G., Di Fino, G., Scavone, C., Sanguedolce, F., Loizzi, V., Carrieri, G."Surgicel® granuloma mimicking ovarian cancer: A case report". Oncology Letters 12, no. 2 (2016): 1083-1084. https://doi.org/10.3892/ol.2016.4689